The new LDL-C target <55 mg/dL is achieved by less than 40% of very high risk patients with familial hypercholesterolaemia despite receiving PCSK9 inhibitors: real world data

被引：0

作者：

Rallidis, L. ^{[1
]}

Vlachopoulos, C. ^{[2
]}

Liberopoulos, E. ^{[3
]}

Skoumas, I ^{[2
]}

Kiouri, E. ^{[1
]}

Koutagiar, I ^{[2
]}

Anastasiou, G. ^{[3
]}

Kosmas, N. ^{[1
]}

Tousoulis, D. ^{[2
]}

Iliodromitis, E. ^{[1
]}

机构：

[1] Attikon Univ Hosp, Athens, Greece

[2] Hippokrateion Hosp, Cardiol Dept, Athens, Greece

[3] Univ Hosp Ioannina, Dept Internal Med, Ioannina, Greece

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2999 / 2999

页数：1

The new LDL-C target &lt;55 mg/dL is achieved by less than 40% of very high risk patients with familial hypercholesterolaemia despite receiving PCSK9 inhibitors: real world data